Ask AI
Surovatamig RR FL
Phase I Trial of CD19 x CD3 T-Cell Engager Surovatamig (AZD0486) in R/R Follicular Lymphoma: 3-Yr Follow-up

Released: December 12, 2025

Activity

Progress
1
Course Completed
Activity Information

Released: December 12, 2025